COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,687 Articles (22,913 medRxiv, 8,774 bioRxiv)

Most recent first Previous |  Page 1834: Articles 18331-18340  | Next

Harnessing recombinase polymerase amplification for rapid detection of SARS-CoV-2 in resource-limited settings
Cherkaoui, D., Huang, D., Miller, B., McKendry, R. A.
10.1101/2021.02.17.21251732 — Posted: 2021-02-19
Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study
Munblit, D., Bobkova, P., Spiridonova, E., Shikhaleva, A., Gamirova, A., Blyuss, O., Nekliudov, N. A., Bugaeva, P., Andreeva, M., DunnGalvin, A., Comberiati, P., Apfelbacher, C., Genuneit, J., Avdeev, S., Kapustina, V., Guekht, A., Fomin, V., Svistunov, A. A., Timashev, P., Drake, T. M., Hanson, S. W., Merson, L., Horby, P., Sigfrid, L., Scott, J. T., Semple, M. G., Warner, J. O., Vos, T., Olliaro, P., Glybochko, P., Butnaru, D., Sechenov StopCOVID Research Team
10.1101/2021.02.17.21251895 — Posted: 2021-02-19 Discussion: Onsite
COVID-BioB Cohort Study: the neutralizing antibody response to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for virus control and survival.
Dispinseri, S., Secchi, M., Pirillo, M. F., Tolazzi, M., Borghi, M., Brigatti, C., De Angelis, M. L., Baratella, M., Bazzigaluppi, E., Venturi, G., Sironi, F., Canitano, A., Marzinotto, I., Tresoldi, C., Ciceri, F., Piemonti, L., Negri, D., Cara, A., Lampasona, V., Scarlatti, G.
10.1101/2021.02.17.21251929 — Posted: 2021-02-19
Associations of Race/Ethnicity and Other Demographic and Socioeconomic Factors with Vaccination During the COVID-19 Pandemic in the United States
Kim, D.
10.1101/2021.02.16.21251769 — Posted: 2021-02-19
Experiences of supported isolation in returning travellers during the early COVID-19 response: an interview study
Carter, H., Weston, D., Greenberg, N., Oliver, I., Robin, C., Rubin, G. J., Wessely, S., Amlot, R.
10.1101/2021.02.17.21251735 — Posted: 2021-02-19
Knowledge, attitudes and perceptions towards COVID-19 vaccinations: a cross-sectional community survey in Bangladesh
Islam, M. S., Siddique, A. B., Akter, R., Tasnim, R., Sujan, M. S. H., Ward, P. R., Sikder, M. T.
10.1101/2021.02.16.21251802 — Posted: 2021-02-19
Antimicrobial use in COVID-19 patients in the first phase of the SARS-CoV-2 pandemic: Rapid review and evidence synthesis
Cong, W., Poudel, N., Alhusein, N., Wang, H., Yao, G., Lambert, H.
10.1101/2021.02.18.21251932 — Posted: 2021-02-19
The impact of COVID-19 on children with oesophageal atresia and/or tracheo-oesophageal fistula (OA/TOF)
Stewart, A., Smith, C., Eaton, S., De Coppi, P., Wray, J.
10.1101/2021.02.17.21251622 — Posted: 2021-02-19
covid19.Explorer: A web application and R package to explore United States COVID-19 data
Revell, L. J.
10.1101/2021.02.15.21251782 — Posted: 2021-02-19
Use of convalescent plasma in patients with coronavirus disease (Covid-19): Systematic review and meta-analysis
Tortosa, F. G., Carrasco, G., Haluska, P., Ragusa, M. A., Izcovich, A.
10.1101/2021.02.14.20246454 — Posted: 2021-02-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).